92 related articles for article (PubMed ID: 6575698)
1. Vasoactive peptides derived from degradation of fibrinogen and fibrin.
Saldeen T
Ann N Y Acad Sci; 1983 Jun; 408():424-37. PubMed ID: 6575698
[No Abstract] [Full Text] [Related]
2. Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin.
Belew M; Gerdin B; Lindeberg G; Porath J; Saldeen T; Wallin R
Biochim Biophys Acta; 1980 Feb; 621(2):169-78. PubMed ID: 7353036
[No Abstract] [Full Text] [Related]
3. Effects of proteolytic degradation products of human fibrinogen and of human factor VIII on platelet aggregation and vascular permeability.
Stachurska J; Lopaciuk S; Gerdin B; Saldeen T; Korościk A; Kopeć M
Thromb Res; 1979; 15(5-6):663-72. PubMed ID: 494170
[No Abstract] [Full Text] [Related]
4. Effect of a fibrin(ogen)-derived vasoactive peptide on polymorphonuclear leukocyte emigration.
Saldeen K; Christie N; Nelson WR; Movat HZ
Thromb Res; 1985 Jan; 37(1):85-9. PubMed ID: 2984802
[TBL] [Abstract][Full Text] [Related]
5. Fibrin-derived vasoactive peptides release histamine.
Eriksson M; Saldeen K; Saldeen T; Strandberg K; Wallin R
Int J Microcirc Clin Exp; 1983; 2(4):337-45. PubMed ID: 6206010
[TBL] [Abstract][Full Text] [Related]
6. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.
Sueishi K; Nanno S; Tanaka K
Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130
[TBL] [Abstract][Full Text] [Related]
7. Effect of fibrin degradation products on microvascular permeability.
Gerdin B; Saldeen T
Thromb Res; 1978 Dec; 13(6):995-1006. PubMed ID: 749269
[No Abstract] [Full Text] [Related]
8. A peptide formed by fibrinolysis increases microvascular permeability and inhibits angiotensin converting enzyme.
Saldeen T; Ryan JW; Ragnarsson U
Adv Exp Med Biol; 1983; 156 (Pt B)():829-34. PubMed ID: 6305169
[No Abstract] [Full Text] [Related]
9. Effect of a peptide derived from fibrinogen degraded by leukocyte elastase on isolated bovine mesenteric arteries.
Saldeen K; Andersson RG
Thromb Res; 1989 Feb; 53(3):279-86. PubMed ID: 2541516
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme dependent and non-dependent effects of a fibrinogen-derived pentapeptide on microvascular permeability in rat skin.
Eriksson M; Gerdin B; Saldeen T
Ups J Med Sci; 1983; 88(2):95-101. PubMed ID: 6316608
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements for microvascular permeability-increasing ability of peptides. Studies on analogues of a fibrinogen pentapeptide fragment.
Gerdin B; Lindeberg G; Ragnarsson U; Saldeen T; Wallin R
Biochim Biophys Acta; 1983 Jun; 757(3):366-70. PubMed ID: 6849982
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies on synthetic analogs to vasoactive peptides derived from human fibrinogen.
Belew M; Gerdin B; Larsson LE; Lindeberg G; Ragnarsson U; Saldeen T; Wallin R
Biochim Biophys Acta; 1980 Sep; 632(1):87-94. PubMed ID: 7417520
[TBL] [Abstract][Full Text] [Related]
13. A fibrin(ogen) derived pentapeptide induces vasodilation, prostacyclin release and an increase in cyclic AMP.
Andersson RG; Saldeen K; Saldeen T
Thromb Res; 1983 May; 30(3):213-8. PubMed ID: 6306861
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the permeability-increasing effect of bradykinin and substance P by a peptide derived from fibrinogen.
Eriksson M; Gerdin B; Saldeen T
Int J Microcirc Clin Exp; 1983; 2(1):53-9. PubMed ID: 6206007
[TBL] [Abstract][Full Text] [Related]
15. Fragment E derived from both fibrin and fibrinogen stimulates interleukin-6 production in rat peritoneal macrophages.
Lee ME; Rhee KJ; Nham SU
Mol Cells; 1999 Feb; 9(1):7-13. PubMed ID: 10102564
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen degradation product fragment D increases endothelial monolayer permeability.
Ge M; Ryan TJ; Lum H; Malik AB
Am J Physiol; 1991 Oct; 261(4 Pt 1):L283-9. PubMed ID: 1928363
[TBL] [Abstract][Full Text] [Related]
17. Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP.
Freedman JE; Fabian A; Loscalzo J
Am J Physiol; 1995 Feb; 268(2 Pt 1):C520-6. PubMed ID: 7532361
[TBL] [Abstract][Full Text] [Related]
18. Depression of phagocytosis by plasmin degradation products of plasma fibronectin.
Ehrlich MI; Krushell JS; Blumenstock FA; Kaplan JE
J Lab Clin Med; 1981 Aug; 98(2):263-71. PubMed ID: 7252334
[TBL] [Abstract][Full Text] [Related]
19. The stimulatory capacity of soluble fibrin prepared from high and low molecular weight fibrinogen on plasminogen activation.
Halvorsen S; Skjønsberg OH; Godal HC
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):133-7. PubMed ID: 8457641
[TBL] [Abstract][Full Text] [Related]
20. Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction.
Rowland FN; Donovan MJ; Picciano PT; Wilner GD; Kreutzer DL
Am J Pathol; 1984 Dec; 117(3):418-28. PubMed ID: 6507588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
